Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Extraction of membrane cholesterol and incorporation of cholesteryl hemisuccinate into the membrane affect the activity of the membrane-bound
Mg2+-ATPase
. Increasing the ratio of cholesterol to phospholipid from 0.30 mg/mg in the control membranes to 0.45-0.90 in the enriched membranes results in a slight increase of the activity of about 20%. Diminishing the ratio of cholesterol to phospholipid to about one tenth of the ratio of the control membrane results in a decrease of the activity to about 30% of the untreated control. Benzyl alcohol inactivates the membrane-bound enzyme.
Digitonin
-solubilized
Mg2+-ATPase
is also inactivated by benzyl alcohol. For concentrations below 20 mM the dependence of the solubilized and the membrane-bound enzymes are virtually identical, and linearly dependent on alcohol concentration. This linear relationship continues up to 70 mM for the solubilized enzyme, while inhibition of the membrane-bound form shows a slightly steeper dependence on inhibitor concentration. It is suggested that the activity of the native
Mg2+-ATPase
depends on the organization of the lipid phase of the membrane and that addition of benzyl alcohol or depletion of cholesterol results in a disorganization of the lipid phase which in turn results in diminished activity.
...
PMID:The effect of changes of the content of membrane cholesterol and the effect of benzyl alcohol on the activity of the intrinsic Mg2+-ATPase from the erythrocyte plasma membrane of the flounder (Platichthys flesus L.). 293 10